美股市场个股详情
RVMD Revolution Medicines
- 56.780
- -0.290-0.51%
收盘价 11/21 16:00 (美东)
- 58.750
- +1.970+3.47%
盘后 20:01 (美东)
95.51亿总市值-15513市盈率TTM
58.825最高价56.500最低价86.49万股成交量57.530今开57.070昨收4962.57万成交额0.56%换手率亏损市盈率(静)1.68亿总股本62.40052周最高6.10市净率87.24亿流通值20.98052周最低--股息TTM1.54亿流通股62.400历史最高--股息率TTM4.07%振幅14.080历史最低57.378平均价1股每手
关于Revolution Medicines公司
Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。 该公司的产品包括RMC-4630，SHP2抑制剂，RAS（ON） 产品组合以及SOS1和4EBP1 / mTORC1程序。
公司介绍
公司代码RVMD
公司名称Revolution Medicines
上市日期2020/02/13
发行价格17.00
成立日期2004
CEODr. Mark A. Goldsmith, M.D., PhD
所属市场纳斯达克
员工数量378
年结日12-31
公司地址700 Saginaw Drive
城市Redwood City
省份加利福尼亚州
国家美国
邮编94063
电话1-650-481-6801
董事高管
- 姓名
- 职务
- 年薪
- Dr. Mark A. Goldsmith, M.D., PhD
- President, Chief Executive Officer and Chairman of the Board
- 1041.12万
- Jack Anders
- Chief Financial Officer and Principal Accounting Officer
- 304.75万
- Dr. Wei Lin
- Chief Medical Officer
- --
- Margaret A. Horn, J.D.
- Chief Operating Officer
- 439.34万
- Ryan Asay
- Senior Vice President, Corporate Affairs
- --
- Dr. Mason Shih, M.D.
- Senior Vice President, Head of Drug Safety
- --
- Dr. Mary Pinder-Schenck, M.D.
- Senior Vice President, Head of Medical Affairs
- --
- Dr. Jing Yi, PhD
- Senior Vice President, Head of Program Leadership.
- --
- Xiaolin Wang
- Executive Vice President, Development
- 323.09万
- Jeff Cislini
- Senior Vice President, General Counsel and Secretary
- --
- Dr. Stephen M. Kelsey, F.R.C.P.,M.D.
- President, Research and Development
- 439.45万
- Dr. Sushil Patel, PhD
- Independent Director
- 47.52万
- Frank K. Clyburn, Jr
- Independent Director
- --
- Alexis A. Borisy, A.M.
- Lead Independent Director
- 51.06万
- Dr. Barbara L. Weber, M.D.
- Independent Director
- 48.02万
- Dr. Thilo Schroeder, PhD
- Independent Director
- --
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 72.00万
- Dr. Flavia Borellini, PhD
- Independent Director
- 48.91万
- Elizabeth McKee Anderson, M.B.A.
- Independent Director
- 48.38万
- Dr. Lorence H. Kim, M.D.
- Independent Director
- 49.00万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据